Position in ICLR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,472,984
+$1,741,377 QoQ
Shares Held
19,993
+27.8% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#144
of 422 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 78%
Shared 0%
None 22%
Common Shares in ICLR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026KENNEDY CAPITAL MANAGEMENT LLC holds $76,192,428 across 12 Diagnostics & Research names. ICLR ranks #6 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PSNL |
Personalis, Inc.
|
2,364,282 | $31,681,378 | |
| 2 | CRL |
Charles River Laboratories International, Inc.
|
43,719 | $9,915,032 | |
| 3 | CSTL |
Castle Biosciences Inc
|
348,371 | $8,308,648 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
13,440 | $6,738,278 | |
| 5 | A |
Agilent Technologies, Inc.
|
43,014 | $5,713,549 | |
| 6 | ICLR |
Icon PLC
This page
|
19,993 | $3,472,984 | |
| 7 | VCYT |
Veracyte, Inc.
|
52,978 | $3,111,397 | |
| 8 | DHR |
Danaher Corp /De/
|
14,347 | $2,732,816 |
All Filings in ICLR
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,472,984 | 19,993 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,731,607 | 15,648 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $3,310,208 | 18,166 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,311,400 | 13,208 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,989,610 | 13,679 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $4,217,783 | 24,103 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $5,374,447 | 25,628 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $4,530,878 | 15,770 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,165,358 | 16,478 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,330,395 | 12,890 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,206,813 | 7,796 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,690,013 | 6,863 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,539,480 | 6,153 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $653,585 | 3,060 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $594,405 | 3,060 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $543,069 | 2,955 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $968,649 | 4,470 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $1,091,814 | 4,489 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,050,192 | 3,391 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,218,393 | 4,650 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $888,026 | 4,296 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $804,920 | 4,099 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $415,697 | 2,132 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $256,251 | 1,341 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $225,231 | 1,337 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||